| NO. | dbSNP_ID | variation | validated |
| 1 | rs144276105 | S5R | Frequency |
| 2 | rs116733978 | R8* | Cluster,Frequency,1000Genome |
| 3 | rs115514161 | R8Q | Cluster,Frequency,1000Genome |
| 4 | rs202194743 | D42V | Cluster |
| 5 | rs115346350 | R47C | 1000Genome |
| 6 | rs7251081 | G64S | Cluster,Frequency,1000Genome |
| 7 | rs192599339 | E96D | 1000Genome |
| 8 | rs114158631 | V120M | 1000Genome |
| 9 | rs966384 | P133S | Cluster,Frequency,1000Genome |
| 10 | rs139572824 | F136L | Frequency |
| 11 | rs146014281 | L145V | Cluster |
| 12 | rs114295397 | E197K | Cluster,Frequency,1000Genome |
| 13 | rs149316385 | R216W | Frequency |
| 14 | rs116144652 | P234L | Cluster,Frequency,1000Genome |
| 15 | rs116652365 | L248P | Cluster,Frequency,1000Genome |
| 16 | rs114858360 | R250S | Frequency,1000Genome |
| 17 | rs150365846 | R260W | Cluster,Frequency,1000Genome |
| 18 | rs149207556 | L262M | Cluster |
| 19 | rs145196834 | N270I | Frequency |
| 20 | rs139646557 | L279F | Cluster |
| 21 | rs144112190 | R291Q | Frequency |
| 22 | rs146810940 | R291W | Frequency |
| 23 | rs148677930 | R328H | Frequency |
| 24 | rs202102463 | T339M | Cluster |
| NO. | dbDEPC_ID | change | ratio | cancer name | design | sample_control | sample_case | sample | pubmed |
| 1 | EXP00295 |  | 1.2 | Ovarian Cancer | Normal vs. Cancer | serum of non-cancer controls | serum of ovarian carcinoma | tissue | 20162585   |
| 2 | EXP00295 |  | 1.4 | Ovarian Cancer | Normal vs. Cancer | serum of non-cancer controls | serum of ovarian carcinoma | tissue | 20162585   |
| 3 | EXP00295 |  | 1.5 | Ovarian Cancer | Normal vs. Cancer | serum of non-cancer controls | serum of ovarian carcinoma | tissue | 20162585   |
| 4 | EXP00111 |  | 1.9 | Hepatocellular Carcinoma | Treatment (none vs curative radiofrequency ablation treatment) | serum samples of HCC patient before treatment | serum samples of HCC patients after curative radiofrequency ablation treatment | tissue | 16254924   |
| 5 | EXP00291 |  | 3.1 | Ovarian Cancer | Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) | "chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months)" | "chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months)" | tissue | 19422301   |